Biomedical Engineering Reference
In-Depth Information
[4] Zempsky WT. Alternative routes of drug administration—advantages and disadvantages
(subject review). Pediatrics 1998;100:143-52.
[5] Van de Weert M, Jorgensen L, Horn Moeller E, Frokjaer S. Factors of importance for a
[5] Van de Weert M, Jorgensen L, Horn Moeller E, Frokjaer S. Factors of importance for a
successful delivery system for proteins. Expert Opin Drug Deliv 2005;2:1029-37.
[6] Arora P, Sharma S, Garg S. Permeability issues in nasal drug delivery. Drug Discov
[6] Arora P, Sharma S, Garg S. Permeability issues in nasal drug delivery. Drug Discov
Today 2002;7:967-75.
[7] Rohan LC, Sassi AB. Vaginal drug delivery systems for HIV prevention. AAPS J
[7] Rohan LC, Sassi AB. Vaginal drug delivery systems for HIV prevention. AAPS J
2009;11:78-87.
[8] Harris D, Robinson JR. Drug delivery via the mucous membranes of the oral cavity.
[8] Harris D, Robinson JR. Drug delivery via the mucous membranes of the oral cavity.
J Pharm Sci 1992;81:1-10.
[9] Gupta H, Bhandari D, Sharma A. Recent trends in oral drug delivery: a review. Recent
[9] Gupta H, Bhandari D, Sharma A. Recent trends in oral drug delivery: a review. Recent
Pat Drug Deliv Formul 2009;3:162-73.
[10] Sastry SV, Nyshadham JR, Fix JA. Recent technological advances in oral drug delivery—
a review. Pharm Sci Technol Today 2000;3:138-45.
[11] Madhav NV, Shakya AK, Shakya P, Singh K. Orotransmucosal drug delivery systems: a
review. J Control Release 2009;140:2-11.
[12] Chiappin S, Antonelli G, Gatti R, De Palo EF. Saliva specimen: a new laboratory tool for
diagnostic and basic investigation. Clin Chim Acta 2007;383:30-40.
[13] Saffran M, Kumar GS, Savariar C, Burnham JC, Williams F, Neckers DC. A new
approach to the oral administration of insulin and other peptide drugs. Science
1986;233:1081-4.
[14] Fix JA. Oral controlled release technology for peptides: status and future prospects.
Pharm Res 1996;13:1760-4.
[15] Vincent HLLee, Satish DK, George MG, Werner R. Oral route of protein and pep-
tide drug delivery. In: Lee Vincent HL, editor. Protein and peptide drug delivery: oral
approaches. New York, NY: Marcel Dekker; 1991. p. 691-738.
[16] Sinha V, Singh A, Kumar RV, Singh S, Kumria R, Bhinge J. Oral colon-specific drug
delivery of protein and peptide drugs. Crit Rev Ther Drug Carrier Syst 2007;24:63-92.
[17] Pettit DK, Gombotz WR. The development of site-specific drug-delivery systems for
protein and peptide biopharmaceuticals. Trends Biotechnol 1998;16:343-9.
[18] Shen WC. Oral peptide and protein delivery: unfulfilled promises? Drug Discov Today
2003;8:607-8.
[19] Goldberg M, Gomez-Orellana I. Challenges for the oral delivery of macromolecules. Nat
Rev Drug Discov 2003;2:289-95.
[20] Lavelle EC, O'Hagan DT. Delivery systems and adjuvants for oral vaccines. Expert Opin
Drug Deliv 2006;3:747-62.
[21] Bernkop-Schnürch A, Dundalek K. Novel bioadhesive drug delivery system protecting
(poly) peptides from gastric enzymatic degradation. Int J Pharm 1996;138:75-83.
[22] Lehr CM. Bioadhesion technologies for the delivery of peptide and protein drugs to the
gastrointestinal tract. Crit Rev Ther Drug Carrier Syst 1994;11:119-60.
[23] Semalty A, Semalty M, Singh R, Saraf SK, Saraf S. Properties and formulation of oral
drug delivery systems of protein and peptides. Indian J Pharm Sci 2007;69:741-7.
[24] Allémann E, Leroux J, Gurny R. Polymeric nano- and microparticles for the oral delivery
of peptides and peptidomimetics. Adv Drug Deliv Rev 1998;34:171-89.
[25] Vigl C. Multifunctional polymeric excipients in oral macromolecular drug delivery. In:
Bernkop-Schnurch A, editor. Oral delivery of macromolecular drugs. New York, NY:
Springer; 2009. p. 137-52.
[26] Tang P, Wang N, Steven MD. Oral delivery of macromolecular drugs. Polymeric Drug
Delivery I. ACS Symp Ser 2006;923:68-83.
Search WWH ::
Custom Search